In a healthy person, immune cells are highly effective at protecting our bodies from foreign pathogens or cancer cells. However, if they are insufficient in number, fail to recognize the foreign cells or are unable to function properly, they are likely to become ineffective.

We use a variety of innovative proprietary technologies to address these problems and manufacture naturally occurring and gene-modified immune cell products.

  • Streptamer® technology gives us the ability to quickly and accurately select naturally occuring virus-specific
    T cells from a mixture of cells.
  • OneTouch expansion technology allows for the controlled expansion of virus-specific T cells.
  • T-cellerator® expansion technology allows us to modify and expand naturally occurring T cells to allow them to function effectively in the toxic environment of a tumor.
  • Our CAR and TCR technologies make it possible to modify immune cells, allowing them to target cancer cells via a wider range of markers.